{
    "clinical_study": {
        "@rank": "153257", 
        "arm_group": {
            "arm_group_label": "Arm I", 
            "arm_group_type": "Experimental", 
            "description": "Patients receive oral fenretinide 3 times a day on days 1-7. Treatment repeats every 3 weeks for up to 8 courses. Patients may receive an additional 22 courses of therapy in the presence of stable or responding residual tumor. Patients with recurrent neuroblastoma, after prior myeloablative therapy with no measurable disease, will stop treatment after 8 courses. Cohorts of 3-6 patients receive escalating doses of fenretinide until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at which 2 of 6 patients experience dose limiting toxicity."
        }, 
        "brief_summary": {
            "textblock": "Phase I trial to study the effectiveness of fenretinide in treating children who have solid\n      tumors that have not responded to standard therapy. Drugs used in chemotherapy use different\n      ways to stop tumor cells from dividing so they stop growing or die."
        }, 
        "brief_title": "Fenretinide in Treating Children With Solid Tumors", 
        "condition": [
            "Neuroblastoma", 
            "Unspecified Childhood Solid Tumor, Protocol Specific"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neuroblastoma", 
                "Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n      I. Determine the maximum tolerated dose of fenretinide (HPR) in children with high risk\n      solid tumors.\n\n      II. Determine the toxicities of HPR in these patients. III. Determine the pharmacokinetics\n      of HPR in these patients. IV. Determine the CSF level of HPR in patients whom cerebrospinal\n      fluid is obtained for routine purposes while on this study.\n\n      V. Determine the effect of HPR on plasma retinol levels in these patients. VI. Determine the\n      activity of HPR in these patients. VII. Determine the antitumor activity of HPR on minimal\n      residual bone marrow disease in neuroblastoma.\n\n      OUTLINE: This is a dose escalation study.\n\n      Patients receive oral fenretinide 3 times a day on days 1-7. Treatment repeats every 3 weeks\n      for up to 8 courses. Patients may receive an additional 22 courses of therapy in the\n      presence of stable or responding residual tumor. Patients with recurrent neuroblastoma,\n      after prior myeloablative therapy with no measurable disease, will stop treatment after 8\n      courses. Cohorts of 3-6 patients receive escalating doses of fenretinide until the maximum\n      tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at which 2\n      of 6 patients experience dose limiting toxicity.\n\n      Patients are followed until death."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically confirmed malignant solid tumor that is refractory to conventional\n             therapy or recurrent neuroblastoma treated with myeloablative therapy and autologous\n             stem cell transplant in second complete or partial response\n\n          -  Bone marrow metastases with granulocytopenia, anemia, and/or thrombocytopenia are\n             eligible\n\n        PATIENT CHARACTERISTICS:\n\n          -  Age: Under 21 at diagnosis\n\n          -  Performance status: CCG 0-2\n\n          -  Life expectancy: At least 2 months\n\n          -  Absolute neutrophil count at least 750/mm3\n\n          -  Platelet count at least 50,000/mm3\n\n          -  Hemoglobin at least 7.0 g/dL\n\n          -  Bilirubin no greater than 1.5 mg/dL\n\n          -  SGOT and SGPT less than 2.5 times normal\n\n          -  Creatinine no greater than 1.5 g/dL OR creatinine clearance at least 50 mL/min OR\n             radioisotope GFR at least 50 mL/min\n\n          -  Seizure disorders controlled with anticonvulsants allowed\n\n          -  No CNS toxicity greater than grade 2\n\n          -  Not pregnant\n\n          -  Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY:\n\n          -  At least 1 month since prior autologous stem cell transplantation\n\n          -  No prior allogeneic transplantation\n\n          -  At least 2 weeks since prior chemotherapy (4 weeks for nitrosourea) and recovered\n\n          -  No other concurrent chemotherapy\n\n          -  No concurrent immunomodulating agents (including steroids)\n\n          -  Concurrent corticosteroid therapy for increased intracranial pressure allowed\n\n          -  Concurrent dexamethasone for CNS tumor allowed\n\n          -  At least 2 weeks since prior radiotherapy\n\n          -  Concurrent radiotherapy to localized lesions allowed\n\n          -  At least 2 weeks since prior retinoids Prior isotretinoin or 9-cis-retinoic acid\n             allowed"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "21 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003191", 
            "org_study_id": "NCI-2012-02262", 
            "secondary_id": [
                "CCG-09709", 
                "CDR0000066023"
            ]
        }, 
        "intervention": {
            "arm_group_label": "Arm I", 
            "intervention_name": "fenretinide", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Fenretinide"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "recurrent neuroblastoma", 
            "unspecified childhood solid tumor, protocol specific"
        ], 
        "lastchanged_date": "February 6, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/CCG-09709"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Duarte", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91010-3000"
                    }, 
                    "name": "Cancer Center and Beckman Research Institute, City of Hope"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90806"
                    }, 
                    "name": "Long Beach Memorial Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90027-0700"
                    }, 
                    "name": "Children's Hospital Los Angeles"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095-1781"
                    }, 
                    "name": "Jonsson Comprehensive Cancer Center, UCLA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92868"
                    }, 
                    "name": "Children's Hospital of Orange County"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143-0128"
                    }, 
                    "name": "UCSF Cancer Center and Cancer Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010-2970"
                    }, 
                    "name": "Children's National Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202-5289"
                    }, 
                    "name": "Indiana University Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109-0752"
                    }, 
                    "name": "University of Michigan Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55905"
                    }, 
                    "name": "Mayo Clinic Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64108"
                    }, 
                    "name": "Children's Mercy Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Brunswick", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08901"
                    }, 
                    "name": "Cancer Institute of New Jersey"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Herbert Irving Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "NYU School of Medicine's Kaplan Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229-3039"
                    }, 
                    "name": "Children's Hospital Medical Center - Cincinnati"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43205-2696"
                    }, 
                    "name": "Children's Hospital of Columbus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Children's Hospital of Philadelphia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213"
                    }, 
                    "name": "Children's Hospital of Pittsburgh"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232-6838"
                    }, 
                    "name": "Vanderbilt-Ingram Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030-4009"
                    }, 
                    "name": "University of Texas - MD Anderson Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84113"
                    }, 
                    "name": "Primary Children's Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98105"
                    }, 
                    "name": "Children's Hospital and Regional Medical Center - Seattle"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53792-6164"
                    }, 
                    "name": "University of Wisconsin Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Perth", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6001"
                    }, 
                    "name": "Princess Margaret Hospital for Children"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase I Study of Fenretinide (NSC #374551) in Children With High Risk Solid Tumors", 
        "overall_official": {
            "affiliation": "Children's Hospital Los Angeles", 
            "last_name": "Judith G. Villablanca, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2005", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003191"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "16849757", 
                "citation": "Children's Oncology Group (CCG 09709); Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709). J Clin Oncol. 2006 Jul 20;24(21):3423-30. Erratum in: J Clin Oncol. 2006 Sep 1;24(25):4223. Reynolds, Patrick C [corrected to Reynolds, C Patrick]."
            }, 
            {
                "citation": "Villablanca JG, Ames MW, Reid JM, et al.: Phase I trial of oral [N-(-4-hydroxyphenyl)retinamide] (4-HPR) in children with resistant/recurrent solid tumors: a children's cancer group study (CCG 09709). [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-1588, 2002."
            }
        ], 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "March 1998", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2006"
    }, 
    "geocoordinates": {
        "Cancer Center and Beckman Research Institute, City of Hope": "34.139 -117.977", 
        "Cancer Institute of New Jersey": "40.486 -74.452", 
        "Children's Hospital Los Angeles": "34.052 -118.244", 
        "Children's Hospital Medical Center - Cincinnati": "39.103 -84.512", 
        "Children's Hospital and Regional Medical Center - Seattle": "47.606 -122.332", 
        "Children's Hospital of Columbus": "39.961 -82.999", 
        "Children's Hospital of Orange County": "33.788 -117.853", 
        "Children's Hospital of Philadelphia": "39.952 -75.164", 
        "Children's Hospital of Pittsburgh": "40.441 -79.996", 
        "Children's Mercy Hospital": "39.1 -94.579", 
        "Children's National Medical Center": "38.895 -77.036", 
        "Herbert Irving Comprehensive Cancer Center": "40.714 -74.006", 
        "Indiana University Cancer Center": "39.769 -86.158", 
        "Jonsson Comprehensive Cancer Center, UCLA": "34.052 -118.244", 
        "Long Beach Memorial Medical Center": "33.804 -118.158", 
        "Mayo Clinic Cancer Center": "44.022 -92.47", 
        "Memorial Sloan-Kettering Cancer Center": "40.714 -74.006", 
        "NYU School of Medicine's Kaplan Comprehensive Cancer Center": "40.714 -74.006", 
        "Primary Children's Medical Center": "40.761 -111.891", 
        "Princess Margaret Hospital for Children": "-31.953 115.857", 
        "UCSF Cancer Center and Cancer Research Institute": "37.775 -122.419", 
        "University of Michigan Comprehensive Cancer Center": "42.281 -83.743", 
        "University of Minnesota Cancer Center": "44.98 -93.264", 
        "University of Texas - MD Anderson Cancer Center": "29.76 -95.369", 
        "University of Wisconsin Comprehensive Cancer Center": "43.073 -89.401", 
        "Vanderbilt-Ingram Cancer Center": "36.166 -86.784"
    }
}